World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
12071
World Ranking
3958
National Ranking
1812

Xingxing Zang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Xingxing Zang sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 144 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Xingxing Zang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Xingxing Zang sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Xingxing Zang is affiliated with the Albert Einstein College of Medicine in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions in Oncology, Immunology, Molecular Biology, Genetics, and Pulmonary and Respiratory Medicine.

Their work is focused on several key topics including Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune cells in cancer, Immune Cell Function and Interaction, Glioma Diagnosis and Treatment, and Lymphoma Diagnosis and Treatment.

Xingxing Zang has published extensively, with notable papers including:

  • Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance (2021) in Clinical Cancer Research
  • KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target (2021) in Science Immunology
  • Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies (2023) in Cellular and Molecular Immunology
  • Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell-mediated antitumor immunity (2022) in Journal of Clinical Investigation
  • Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma (2023) in Clinical Cancer Research

Frequent coauthors in their research include Deyou Zheng, Phillip M. Galbo, Xiaoxin Ren, R. Alejandro Sica, and Christopher Nishimura.

Their work is regularly published in venues such as Blood, Regular and Young Investigator Award Abstracts, Cancer Research, Clinical Cancer Research, and Cancers.

Best Publications

  • BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.

    Norihiko Watanabe;Norihiko Watanabe;Maya Gavrieli;John R Sedy;Jianfei Yang;Jianfei Yang

  • Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway

    Kim C. Ohaegbulam;Amer Assal;Eszter Lazar-Molnar;Yu Yao

  • B7x: A widely expressed B7 family member that inhibits T cell activation

    Xingxing Zang;P'ng Loke;Jayon Kim;Kenneth Murphy

  • Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy

    Elodie Picarda;Kim C. Ohaegbulam;Xingxing Zang

  • B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

    Xingxing Zang;R. Houston Thompson;Hikmat A. Al-Ahmadie;Hikmat A. Al-Ahmadie;Angel M. Serio

  • The B7 Family and Cancer Therapy: Costimulation and Coinhibition

    Xingxing Zang;James P. Allison

  • Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance

    Phillip M Galbo;Xingxing Zang;Deyou Zheng

  • Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection

    P'ng Loke;Iain Gallagher;Meera G Nair;Meera G Nair;Xingxing Zang

  • Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

    Xingxing Zang;Peggy S Sullivan;Robert A Soslow;Rebecca Waitz

  • Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma.

    Pratistha Koirala;Michael Roth;Jonathan Benjamin Gill;Sajida Piperdi

  • T Cell Immunoglobulin Mucin-3 Crystal Structure Reveals a Galectin-9-Independent Ligand-Binding Surface

    Erhu Cao;Xingxing Zang;Udupi A. Ramagopal;Arunika Mukhopadhaya

  • HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function

    Ruihua Zhao;Jordan M. Chinai;Susan Buhl;Lisa Scandiuzzi

  • Cell-cell contact with proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models.

    Yanhong Li;Di Zhang;Ling Xu;Lin Dong

  • The contrasting role of B7-H3

    Kimberly A. Hofmeyer;Anjana Ray;Xingxing Zang

  • The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3

    Murali Janakiram;Urvi A. Shah;Weifeng Liu;Aimin Zhao

  • New immunotherapies targeting the PD-1 pathway

    Jordan M. Chinai;Murali Janakiram;Fuxiang Chen;Wantao Chen

  • Immune evasion genes from filarial nematodes.

    Rick M. Maizels;Natalia Gomez-Escobar;William F. Gregory;Janice Murray

  • B7-H4(B7x)–Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients

    Yu Yao;Hongxing Ye;Zengxin Qi;Lianjie Mo

  • Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies.

    Hao Wang;Gurbakhash Kaur;Alexander I. Sankin;Fuxiang Chen

  • The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion

    Kimberly A. Hofmeyer;Hyungjun Jeon;Xingxing Zang

  • A Brugia malayi Homolog of Macrophage Migration Inhibitory Factor Reveals an Important Link Between Macrophages and Eosinophil Recruitment During Nematode Infection

    Franco H. Falcone;P’ng Loke;Xingxing Zang;Andrew S. MacDonald

  • Abstract 4134: Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma

    Pratistha Koirala;Michael Roth;Jonathan Gill;Jordan Chinai

Frequent Co-Authors

James P. Allison
James P. Allison The University of Texas MD Anderson Cancer Center
P'ng Loke
P'ng Loke National Institutes of Health
Rick M. Maizels
Rick M. Maizels University of Glasgow
Joseph A. Sparano
Joseph A. Sparano Albert Einstein College of Medicine
Judith E. Allen
Judith E. Allen University of Manchester
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
Amit Verma
Amit Verma Albert Einstein College of Medicine
Haobo Jiang
Haobo Jiang Oklahoma State University
Ulrich Steidl
Ulrich Steidl Albert Einstein College of Medicine
Michael R. Kanost
Michael R. Kanost Kansas State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals opt for advanced nursing roles, which provide specialized knowledge and higher earning potential. For example, cheapest pmhnp programs offer affordable pathways to becoming Psychiatric-Mental Health Nurse Practitioners, blending immunology insights with mental health care.

Additionally, understanding earning expectations helps guide career choices. The comprehensive data on dnp salary provides valuable insight into Doctor of Nursing Practice roles nationwide, illustrating financial benefits across states.

For those interested in acute care settings, transitioning roles can be seamless by pursuing acnp programs. These prepare nurse practitioners to manage complex immunological and critical care cases, adding to their clinical expertise.

To accelerate career advancement, many students turn to nurse practitioner accelerated program options, which condense rigorous training into shorter periods, enabling quicker entry into specialized roles within healthcare.

Best Scientists Citing Xingxing Zang

Trending Scientists

Recently Published Articles